How to buy NovaBay Pharmaceuticals stock

NovaBay Pharmaceuticals, Inc is a biotechnology business based in the US. NovaBay Pharmaceuticals shares (NBY) are listed on the NYSE MKT and all prices are listed in US Dollars. NovaBay Pharmaceuticals employs 26 staff and has a trailing 12-month revenue of around USD$9.8 million.

How to buy shares in NovaBay Pharmaceuticals

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for NovaBay Pharmaceuticals. Find the stock by name or ticker symbol: NBY. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until NovaBay Pharmaceuticals reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of NovaBay Pharmaceuticals, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of NovaBay Pharmaceuticals. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Our top pick for

Beginners

Robinhood

Our top pick for

Building a portfolio

Sofi Invest

Our top pick for

Advanced traders

Interactive Brokers

How we chose our top picks

We evaluate stock trading platforms against a range of metrics that include fees, ease of use, available securities and advanced tools to meet specific investor needs. We encourage you to compare stock platforms to find one that's best for your particular budget and goals.

• Our pick for beginners. We chose Robinhood for this category because it offers commission-free trading and is easy to use. You can search for stocks by company name, and the mobile app is clean and intuitive to use.
• Our pick for building a portfolio. We chose SoFi for this category because it offers both commission-free stocks and a free robo-advisor. That means you can open an active investing account to pick and choose companies you want to invest in, and open a robo-advisor account to help you build a portfolio and manage how much risk you take on.
• Our pick for active traders. We picked Interactive Brokers for this category because it offers advanced tools and low fees for active investors and pros. The simpler IBKR Lite platform is aimed at less-active investors, but all users older than 21 must meet a $20,000 liquid net worth requirement for a cash account.

What's in this guide?

1. NBY shares summary
2. Compare share dealing platforms
3. Is NBY stock a buy or sell?
4. Stock performance over time
5. Can I short NBY shares?
6. NovaBay Pharmaceuticals's financials
7. How volatile are NBY shares?
8. Does NovaBay Pharmaceuticals pay a dividend?
9. Have NBY shares ever split?
10. Other common questions

NovaBay Pharmaceuticals share price

Use our graph to track the performance of NBY stocks over time.

NovaBay Pharmaceuticals shares at a glance

• Key figures

Information last updated 2021-03-03.

52-week range	USD$0.24 - USD$1.64
50-day moving average	USD$1.0882
200-day moving average	USD$0.8135
Wall St. target price	USD$2.63
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-0.584

Buy NovaBay Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Sort by:

Name	Product	Stock trade fee	Asset types	Option trade fee	Annual fee	Signup bonus
Robinhood		$0	Stocks, Options, ETFs, Gold/Commodities	$0	0%	Free stock (chosen randomly with a value anywhere between $2.50 and $200) Sign up using the "go to site" link	Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.	Go to site More Info		loading Fetching your data...
Interactive Brokers		$0	Stocks, Bonds, Options	$0 + $0.65/contract, $1 minimum	0%	N/A	IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.	Go to site More Info		loading Fetching your data...
Tastyworks		$0	Stocks, Options, Cryptocurrency	Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg Futures: $2.50/contract to open, $0 to close	0%	Get 100 shares of stock (worth $1 to $6 a share) Open and fund a new cash or margin account with $2,000+	Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.	Go to site More Info		loading Fetching your data...
Moomoo		$0 for US stocks	Stocks, Options, ETFs	$0		N/A	Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.	Go to site More Info		loading Fetching your data...
TradeStation		$0	Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency	$0 + $0.50/contract		$50 Deposit qualifying assets of $5,000+	A platform built for all kinds of traders and all styles of trading	Go to site More Info		loading Fetching your data...

loading

Compare up to 4 providers

Clear selection

Compare

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy NovaBay Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of NovaBay Pharmaceuticals, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Shorting NovaBay Pharmaceuticals shares

There are currently 861,421 NovaBay Pharmaceuticals shares held short by investors – that's known as NovaBay Pharmaceuticals's "short interest". This figure is 17.3% down from 1.0 million last month.

There are a few different ways that this level of interest in shorting NovaBay Pharmaceuticals shares can be evaluated.

NovaBay Pharmaceuticals's "short interest ratio" (SIR)

NovaBay Pharmaceuticals's "short interest ratio" (SIR) is the quantity of NovaBay Pharmaceuticals shares currently shorted divided by the average quantity of NovaBay Pharmaceuticals shares traded daily (recently around 5.7 million). NovaBay Pharmaceuticals's SIR currently stands at 0.15. In other words for every 100,000 NovaBay Pharmaceuticals shares traded daily on the market, roughly 150 shares are currently held short.

However NovaBay Pharmaceuticals's short interest can also be evaluated against the total number of NovaBay Pharmaceuticals shares, or, against the total number of tradable NovaBay Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case NovaBay Pharmaceuticals's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 NovaBay Pharmaceuticals shares in existence, roughly 20 shares are currently held short) or 0.0276% of the tradable shares (for every 100,000 tradable NovaBay Pharmaceuticals shares, roughly 28 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against NovaBay Pharmaceuticals.

Find out more about how you can short NovaBay Pharmaceuticals stock.

Have NovaBay Pharmaceuticals's shares ever split?

NovaBay Pharmaceuticals's shares were split on a 1:25 basis on 21 December 2015. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your NovaBay Pharmaceuticals shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for NovaBay Pharmaceuticals shares which in turn could have impacted NovaBay Pharmaceuticals's share price.

NovaBay Pharmaceuticals share price volatility

Over the last 12 months, NovaBay Pharmaceuticals's shares have ranged in value from as little as $0.24 up to $1.64. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while NovaBay Pharmaceuticals's is 3.6996. This would suggest that NovaBay Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.

NovaBay Pharmaceuticals overview

NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes non-antibiotic anti-infective products to address therapeutic needs of the anti-infective market in the United States and internationally. The company offers Avenova, a solution for cleansing and removing foreign materials, including microorganisms and debris from skin around the eye, including the eyelid; CelleRx for the aesthetic dermatology market; and NeutroPhase for the wound care market. It also develops auriclosene, a synthetic molecule for use against bacteria, viruses, and fungi. The company has a collaboration and license agreement with Virbac to develop auriclosene for veterinary markets for companion animals. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Frequently asked questions

• What percentage of NovaBay Pharmaceuticals is owned by insiders or institutions?

  Currently 25.207% of NovaBay Pharmaceuticals shares are held by insiders and 6.205% by institutions.

• How many people work for NovaBay Pharmaceuticals?

  Latest data suggests 26 work at NovaBay Pharmaceuticals.

• When does the fiscal year end for NovaBay Pharmaceuticals?

  NovaBay Pharmaceuticals's fiscal year ends in December.

• Where is NovaBay Pharmaceuticals based?

  NovaBay Pharmaceuticals's address is: 2000 Powell Street, EmeryVille, CA, United States, 94608

• What is NovaBay Pharmaceuticals's ISIN number?

  NovaBay Pharmaceuticals's international securities identification number is: US66987P2011

• What is NovaBay Pharmaceuticals's CUSIP number?

  NovaBay Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 628729105